New injection shows promise for controlling severe eczema

NCT ID NCT06395948

Ongoing Disease control Sponsor: Apogee Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing an experimental injection called APG777 for people with moderate-to-severe eczema (atopic dermatitis). Researchers want to see if different doses of APG777 can safely reduce skin inflammation and itching better than a placebo. The trial will last up to 2 years and involves 470 participants who haven't responded well to standard creams and ointments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Investigational Site

Fountain Valley, California, 92708, United States
Investigational Site

Los Angeles, California, 90024, United States
Investigational Site

San Diego, California, 92123, United States
Investigational Site

New Haven, Connecticut, 06519, United States
Investigational Site

Coral Gables, Florida, 33134, United States
Investigational Site

Jacksonville, Florida, 32256, United States
Investigational Site

Margate, Florida, 33063, United States
Investigational Site

Douglasville, Georgia, 30135, United States
Investigational Site

Chicago, Illinois, 60657, United States
Investigational Site

Skokie, Illinois, 60077, United States
Investigational Site

West Lafayette, Indiana, 47906, United States
Investigational Site

Bowling Green, Kentucky, 42104, United States
Investigational Site

Rockville, Maryland, 20850, United States
Investigational Site

Detroit, Michigan, 48202, United States
Investigational Site

Troy, Michigan, 48084, United States
Investigational Site

Portsmouth, New Hampshire, 13801, United States
Investigational Site

New York, New York, 10023, United States
Investigational Site

Wilmington, North Carolina, 28403, United States
Investigational Site

Boardman, Ohio, 44512, United States
Investigational Site

Mason, Ohio, 45040, United States
Investigational Site

Portland, Oregon, 97201, United States
Investigational Site

Pittsburgh, Pennsylvania, 15213, United States
Investigational Site

Charleston, South Carolina, 29425, United States
Investigational Site

Nashville, Tennessee, 37215, United States
Investigational Site

Dallas, Texas, 75230, United States
Investigational Site

Dallas, Texas, 75235, United States
Investigational Site

San Antonio, Texas, 78213, United States
Investigational Site

Norfolk, Virginia, 23502, United States
Investigational Site

Mill Creek, Washington, 98012, United States
Investigational Site

Calgary, Alberta, T2J 7E1, Canada
Investigational Site

Calgary, Alberta, T3E 0B2, Canada
Investigational Site

Edmonton, Alberta, T5J 3S9, Canada
Investigational Site

Vancouver, British Columbia, V5Z 4E8, Canada
Investigational Site

Winnipeg, Manitoba, R3M 3Z4, Canada
Investigational Site

Fredericton, New Brunswick, E3B 1G9, Canada
Investigational Site

Ajax, Ontario, L1S 7K8, Canada
Investigational Site

Markham, Ontario, L3P 1X3, Canada
Investigational Site

Mississauga, Ontario, L4Y 4C5, Canada
Investigational Site

Ottawa, Ontario, K1K 4L2, Canada
Investigational Site

Peterborough, Ontario, K9J 5K2, Canada
Investigational Site

Toronto, Ontario, M3B 0A7, Canada
Investigational Site

Toronto, Ontario, M4E 2Y9, Canada
Investigational Site

Toronto, Ontario, M4W 2N4, Canada
Investigational Site

Montreal, Quebec, H2X 2V1, Canada
Investigational Site

Québec, Quebec, G1V4X7, Canada
Investigational Site

Prague, 10000, Czechia
Investigational Site

Prague, 10034, Czechia
Investigational Site

Prague, 11000, Czechia
Investigational Site

Prague, 15006, Czechia
Investigational Site

Prague, 16000, Czechia
Investigational Site

Rouen, Normandy, 76031, France
Investigational Site

Martigues, 13500, France
Investigational Site

Nantes, 44093, France
Investigational Site

Freiburg im Breisgau, Baden-Wurttemberg, 79104, Germany
Investigational Site

Heidelberg, Baden-Wurttemberg, 69120, Germany
Investigational Site

Tübingen, Baden-Wurttemberg, 72076, Germany
Investigational Site

Augsburg, Bavaria, 86179, Germany
Investigational Site

München, Bavaria, 81377, Germany
Investigational Site

Blankenfelde-Mahlow, Brandenburg, 15831, Germany
Investigational Site

Darmstadt, Hesse, 64283, Germany
Investigational Site

Frankfurt am Main, Hesse, 60590, Germany
Investigational Site

Bad Bentheim, Lower Saxony, 48455, Germany
Investigational Site

Münster, North Rhine Westfalia, 48149, Germany
Investigational Site

Dresden, Saxony, 01307, Germany
Investigational Site

Kiel, Schleswig-Holstein, 24105, Germany
Investigational Site

Lübeck, Schleswig-Holstein, 23538, Germany
Investigational Site

Berlin, 10117, Germany
Investigational Site

Hamburg, 20246, Germany
Investigational Site

Hamburg, 20354, Germany
Investigational Site

Debrecen, Hajdú-Bihar, 4032, Hungary
Investigational Site

Budapest, 1085, Hungary
Investigational Site

Szeged, 6720, Hungary
Investigational Site

Wroclaw, Lower Silesian Voivodeship, 50-450, Poland
Investigational Site

Wroclaw, Lower Silesian Voivodeship, 51-503, Poland
Investigational Site

Lublin, Lublin Voivodeship, 20-573, Poland
Investigational Site

Warsaw, Masovian Voivodeship, 01-595, Poland
Investigational Site

Warsaw, Masovian Voivodeship, 02-482, Poland
Investigational Site

Gdansk, Pomeranian Voivodeship, 80-546, Poland
Investigational Site

Katowice, Silesian Voivodeship, 40-600, Poland
Investigational Site

Sosnowiec, Silesian Voivodeship, 41-218, Poland
Investigational Site

Szczecin, West Pomeranian Voivodeship, 71-500, Poland
Investigational Site

Krakow, Woj. Małopolskie, 30-727, Poland
Investigational Site

Lodz, Łódź Voivodeship, 90-338, Poland
Investigational Site

Santiago de Compostela, A Coruña, 15706, Spain
Investigational Site

Badalona, Barcelona, 08916, Spain
Investigational Site

Las Palmas de Gran Canaria, Canary Islands, 35010, Spain
Investigational Site

Alicante, 03010, Spain
Investigational Site

Barcelona, 08041, Spain
Investigational Site

Madrid, 28006, Spain
Investigational Site

Madrid, 28040, Spain
Investigational Site

Zaragoza, 50009, Spain
Investigational Site

Salford, Greater Manchester, M6 8HD, United Kingdom
Investigational Site

Dudley, West Midlands, DY1 2HQ, United Kingdom
Investigational Site

London, SE1 9RT, United Kingdom

Conditions

Explore the condition pages connected to this study.

ATOPIC DERMATITIS